164 related articles for article (PubMed ID: 35117218)
1. Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer.
Feng H; Shao W; Du L; Qing X; Zhang Z; Liang C; Liu D
Transl Cancer Res; 2020 Oct; 9(10):6070-6077. PubMed ID: 35117218
[TBL] [Abstract][Full Text] [Related]
2. miR-375 Combined with SHOX2 Methylation has Higher Diagnostic Efficacy for Non-Small-Cell Lung Cancer.
Zeng S; Lin C; Huang Y
Mol Biotechnol; 2023 Jul; 65(7):1187-1197. PubMed ID: 36462101
[TBL] [Abstract][Full Text] [Related]
3. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
Ilse P; Biesterfeld S; Pomjanski N; Wrobel C; Schramm M
Cancer Genomics Proteomics; 2014; 11(5):251-8. PubMed ID: 25331797
[TBL] [Abstract][Full Text] [Related]
4. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
[TBL] [Abstract][Full Text] [Related]
5. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.
Schneider KU; Dietrich D; Fleischhacker M; Leschber G; Merk J; Schäper F; Stapert HR; Vossenaar ER; Weickmann S; Liebenberg V; Kneip C; Seegebarth A; Erdogan F; Rappold G; Schmidt B
BMC Cancer; 2011 Mar; 11():102. PubMed ID: 21426551
[TBL] [Abstract][Full Text] [Related]
6. [DNA methylation detection of SHOX2 and PTGER4 in plasma contributes to differential diagnosis of pulmonary nodule patients].
Chu X; Zhao W; Wang B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Apr; 35(4):357-361. PubMed ID: 31167696
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
[TBL] [Abstract][Full Text] [Related]
8. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
9. Early Dynamics of Quantitative
Krausewitz P; Kluemper N; Richter AP; Büttner T; Kristiansen G; Ritter M; Ellinger J
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139516
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of exfoliated tumor cells combined with DNA methylation in bronchoalveolar lavage fluid for lung cancer.
Lu H; Lin D
Medicine (Baltimore); 2023 Sep; 102(36):e34955. PubMed ID: 37682182
[TBL] [Abstract][Full Text] [Related]
11. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
[TBL] [Abstract][Full Text] [Related]
12. Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma.
Zhao J; Lu Y; Ren X; Bian T; Feng J; Sun H; Liu L; She B; Liu Y; Ke H
BMC Cancer; 2024 Jun; 24(1):687. PubMed ID: 38840077
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis.
Zhang C; Yu W; Wang L; Zhao M; Guo Q; Lv S; Hu X; Lou J
J Cancer; 2017; 8(17):3585-3591. PubMed ID: 29151944
[No Abstract] [Full Text] [Related]
14. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
[TBL] [Abstract][Full Text] [Related]
15. DNA Methylation Analysis of the
Zhang N; Liu Z; Li K; Xing X; Long C; Liu F; She B; Che N
J Oncol; 2023; 2023():5888844. PubMed ID: 36691467
[TBL] [Abstract][Full Text] [Related]
16. Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging.
Darwiche K; Zarogoulidis P; Baehner K; Welter S; Tetzner R; Wohlschlaeger J; Theegarten D; Nakajima T; Freitag L
Ann Oncol; 2013 Nov; 24(11):2866-70. PubMed ID: 24026539
[TBL] [Abstract][Full Text] [Related]
17. Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.
Zang R; Wang X; Jin R; Lei Y; Huang J; Liu C; Zheng S; Zhou F; Wu Q; Sun N; Gao S; He J
J Transl Med; 2019 Dec; 17(1):430. PubMed ID: 31888670
[TBL] [Abstract][Full Text] [Related]
18. Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis.
Ni S; Ye M; Huang T
Oncotarget; 2017 Sep; 8(37):61253-61263. PubMed ID: 28977861
[TBL] [Abstract][Full Text] [Related]
19. The Diagnostic Potential of
Gao H; Yang J; He L; Wang W; Liu Y; Hu Y; Ge M; Ding J; Ye Q
Front Oncol; 2022; 12():849024. PubMed ID: 35837113
[TBL] [Abstract][Full Text] [Related]
20. Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.
Nawaz I; Qiu X; Wu H; Li Y; Fan Y; Hu LF; Zhou Q; Ernberg I
Epigenetics; 2014 Aug; 9(8):1138-48. PubMed ID: 24937636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]